Efficacy and safety of apatinib in patients with recurrent or metastatic head and neck squamous cell carcinoma: a retrospective multi-center study

Apatinib is a novel antiangiogenic agent that targets vascular endothelial growth factor 2. The aim of our study was to explore the efficacy and safety of apatinib in the treatment of patients with recurrence or metastasis (R/M) inoperable head and neck squamous cell carcinoma (HNSCC). This multi-ce...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Zijing, Zheng, Zhuangzhuang, Dong, Lihua, Guo, Xiao, Jia, Xiaojing, Wang, Jianfeng, Meng, Lingbin, Cui, Xiangyan, Jiang, Xin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9622845/
https://www.ncbi.nlm.nih.gov/pubmed/36316341
http://dx.doi.org/10.1038/s41598-022-20272-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9622845/
https://www.ncbi.nlm.nih.gov/pubmed/36316341
http://dx.doi.org/10.1038/s41598-022-20272-x

Ejemplares similares